RxDoctor Payments Data

Monica Briones, MD

Family Medicine · Edgewood, NMNPI 1265449094

Payments from drug & device makers

$868in general payments, 2019–2025

Across 48 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$163
  • Amgen$135
  • Otsuka America Pharmaceutical, Inc.$128
  • AstraZeneca$84
  • Bayer$78
  • Novo Nordisk$62
  • plus $219 from 9 others

What the payments were for

  • Food & beverage$85298%
  • Education$152%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$868 in reported general payments places this provider in the 80th percentile of 717 family medicine providers in New Mexico.

See all family medicine providers in New Mexico

Medicare billing

Part B allowed, 2024
$20,383
Medicare patients
121
Services billed
197

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JanuviaSitagliptin Phosphate17$28,020
XareltoRivaroxaban18$27,828
SymbicortBudesonide/Formoterol Fumarate44$18,785
Spiriva HandihalerTiotropium Bromide16$16,869
TrulicityDulaglutide13$14,361
Spiriva RespimatTiotropium Bromide15$10,308
EntrestoSacubitril/Valsartan13$9,226
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl28$7,275
Albuterol Sulfate HfaAlbuterol Sulfate120$4,795
Gabapentin185$3,882
Atorvastatin Calcium263$3,755
Levothyroxine Sodium227$3,737
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$3,220
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$2,673
Fluticasone Propionate88$2,169

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia$33$28,02017 claims
AstraZenecaSymbicort$84$18,78544 claims
Lilly USA, LLCTrulicity$163$14,36113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 717 family medicine providers in New Mexico.

Other family medicine in Edgewood

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →